An Open-label Study to Evaluate the Effect of MabThera in Combination With Methotrexate on Disease Activity in Patients With Active Rheumatoid Arthritis After DMARD Treatment Failure
Phase of Trial: Phase III
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Rituximab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 17 Dec 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health-NCT02006706)
- 22 Jul 2008 Status changed from in progress to completed, as reported by Roche.
- 24 Apr 2007 New trial record.